image
Healthcare - Biotechnology - NASDAQ - US
$ 36.85
-7.34 %
$ 14.2 B
Market Cap
-6.34
P/E
CASH FLOW STATEMENT
-3.12 B OPERATING CASH FLOW
-62.60%
4.21 B INVESTING CASH FLOW
181.26%
-1.38 B FINANCING CASH FLOW
60.06%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Moderna, Inc.
image
Net Income -4.71 B
Depreciation & Amortization 621 M
Capital Expenditures -707 M
Stock-Based Compensation 305 M
Change in Working Capital -139 M
Others -1.41 B
Free Cash Flow -3.82 B

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (4 714.0) 8 362.0 12 202.0 (747.1) (514.0) (384.7) (255.9) (216.2)
Depreciation & Amortization 621.0 348.0 232.0 31.3 31.0 24.9 20.5 15.1
Deferred Income Tax 828.0 (559.0) (318.0) 10.4 0 0 0 0.3
Stock Based Compensation 305.0 226.0 142.0 93.0 81.1 72.6 40.1 39.4
Other Operating Activities (19.0) 59.0 1 044.0 0.5 109.7 5.0 1.1 2.8
Change in Working Capital (139.0) (3 455.0) 990.0 2 577.1 (53.7) (42.6) (137.2) 226.0
Cash From Operations (3 118.0) 4 981.0 13 620.0 2 027.0 (459.0) (330.9) (331.5) 66.7
INVESTING CASH FLOW
Capital Expenditures (707.0) (400.0) (284.0) (67.4) (31.6) (105.8) (58.4) (33.1)
Other Items 4 913.0 (4 776.0) (8 239.0) (1 604.5) 16.6 (266.7) 474.5 (615.5)
Cash From Investing Activities 4 206.0 (5 176.0) (8 523.0) (1 671.9) (14.9) (372.5) 416.1 (648.6)
FINANCING CASH FLOW
Common Stock Repurchased (1 153.0) (3 329.0) (857.0) 0 2.9 (8.2) 0 0
Total Debt Repaid (270.0) (184.0) (140.0) (6.0) 1.0 9.5 1.4 0
Dividends Paid 0 0 0 0 0 0 (1.5) (0.6)
Other Financing Activities 0 0 0 186.2 29 K 652.9 0 473.5
Cash From Financing Activities (1 377.0) (3 448.0) (873.0) 2 033.2 51.1 1 226.8 0.2 472.9
CHANGE IN CASH
Net Change In Cash (289.0) (3 643.0) 4 224.0 2 388.2 (422.8) 523.5 84.8 (109.0)
FREE CASH FLOW
Free Cash Flow (3 825.0) 4 581.0 13 336.0 1 959.5 (490.5) (436.6) (389.9) 33.6